convulsive seizures Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey

Epilepsy Res. 2023 Dec 14:200:107280. doi: 10.1016/j.eplepsyres.2023.107280. Online ahead of print. Anne T Berg 1, Tracy Dixon-Salazar 2, Mary…

Freedom WaresDecember 14, 2023

Canna~Fangled Abstracts

Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: 4-year results from the expanded access program

Epilepsia. 2022 Dec 20. doi: 10.1111/epi.17496. Online ahead of print. Jerzy P Szaflarski 1, Orrin Devinsky 2, Merrick Lopez 3, Yong…

Freedom WaresDecember 20, 2022

Canna~Fangled Abstracts

Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial

Epilepsia. 2021 Aug 18. doi: 10.1111/epi.17036. Online ahead of print. Ingrid E Scheffer 1, Jonathan J Halford 2, Ian…

Freedom WaresAugust 18, 2021

Canna~Fangled Abstracts

Cannabidiol reduced frequency of convulsive seizures in drug resistant Dravet syndrome

Author affiliations http://dx.doi.org/10.1136/archdischild-2017-31370 Published in Archives of Disease in Childhood -- Education & Practice Edition,…

Freedom WaresSeptember 22, 2017

Canna~Fangled Abstracts

Fewer Seizures With Cannabidiol in Catastrophic Epilepsy

Clinical Trials Update July 25, 2017 Anita Slomski, MA JAMA. 2017;318(4):323. doi:10.1001/jama.2017.8846 Cannabidiol reduced the frequency of convulsive…

Freedom WaresJuly 25, 2017

convulsive seizures

Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey

Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: 4-year results from the expanded access program

Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial

Cannabidiol reduced frequency of convulsive seizures in drug resistant Dravet syndrome

Fewer Seizures With Cannabidiol in Catastrophic Epilepsy

Recent Posts

Archives

Categories